Financhill
Back

Brainstorm Cell Therapeutics Vs. BioNTech SE Industry Stock Comparison

Sell
29

BCLI
Brainstorm Cell Therapeutics

Last Price:
0.39
Seasonality Move:
18.66%
Sell
29

BNTX
BioNTech SE

Last Price:
84.38
Seasonality Move:
13.76%
Sell
29
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $0.38. The Score for BCLI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
BioNTech SE (BNTX) is a Sell

Is BioNTech SE a Buy, Sell or Hold?

  • The current BioNTech SE [BNTX] share price is $86.52. The Score for BNTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • BNTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

  • The Brainstorm Cell Therapeutics share price today is $0.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.

BNTX Stock Price Chart

What is BioNTech SE's stock price today?

  • The BioNTech SE share price today is $86.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing slight buying pressure.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 38.27 Sell
Chaikin Money Flow: -94334 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.54) Sell
Bollinger Bands (100): (0.35 - 0.57) Sell

BNTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 37.29 Sell
Chaikin Money Flow: 354895 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.63 - 100.89) Sell
Bollinger Bands (100): (88.37 - 96.23) Sell

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.42 Sell
20-day SMA: 0.45 Sell
50-day SMA: 0.48 Sell
200-day SMA: 0.4 Sell
8-day EMA: 0.41 Sell
20-day EMA: 0.44 Sell
50-day EMA: 0.47 Sell
200-day EMA: 0.67 Sell

BNTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.72 Sell
20-day SMA: 95.26 Sell
50-day SMA: 92.4 Sell
200-day SMA: 97.5 Sell
8-day EMA: 89.21 Sell
20-day EMA: 92.66 Sell
50-day EMA: 93.24 Sell
200-day EMA: 99.08 Sell

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.02 per share.

BioNTech SE Earnings Growth & BNTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.82 per share, a decrease next quarter of $0.67 per share, a decrease this year of $6.67 per share, and a decrease next year of $0.60 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioNTech SE Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):